scispace - formally typeset
Open AccessJournal ArticleDOI

Structure-based model of allostery predicts coupling between distant sites

TLDR
A model that varies the size of the allosteric site and its interactions to construct a series of energy landscapes with pronounced minima corresponding to both the effector bound and unbound crystal structures is applied to three proteins with experimentally characterized transitions.
Abstract
Allostery is a phenomenon that couples effector ligand binding at an allosteric site to a structural and/or dynamic change at a distant regulated site. To study an allosteric transition, we vary the size of the allosteric site and its interactions to construct a series of energy landscapes with pronounced minima corresponding to both the effector bound and unbound crystal structures. We use molecular dynamics to sample these landscapes. The degree of perturbation by the effector, modeled by the size of the allosteric site, provides an order parameter for allostery that allows us to determine how microscopic motions give rise to commonly discussed macroscopic mechanisms: (i) induced fit, (ii) population shift, and (iii) entropy driven. These mechanisms involve decreasing structural differences between the effector bound and unbound populations. A metric (ligand-induced cooperativity) can measure how cooperatively a given regulated site responds to effector binding and therefore what kind of allosteric mechanism is involved. We apply the model to three proteins with experimentally characterized transitions: (i) calmodulin-GFP Ca2+ sensor protein, (ii) maltose binding protein, and (iii) CSL transcription factor. Remarkably, the model is able to reproduce allosteric motion and predict coupling in a manner consistent with experiment.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Allostery in Disease and in Drug Discovery

TL;DR: This work focuses on the challenging questions of how allostery can both cause disease and contribute to development of new therapeutics and aims to increase the awareness of the linkage between disease symptoms on the cellular level and specific aberrant allosteric actions on the molecular level.
Journal ArticleDOI

Emerging Computational Methods for the Rational Discovery of Allosteric Drugs.

TL;DR: Algorithms that predict allosteric sites based on sequence data and molecular dynamics simulations are reviewed, tools that assess the druggability of these pockets are described, and how Markov state models and topology analyses provide insight into the relationship between protein dynamics andallosteric drug binding are discussed.
Journal ArticleDOI

Allostery without a conformational change? Revisiting the paradigm.

TL;DR: It is explained that even if a structural comparison between the active and inactive states does not detect a conformational change, it does not mean that there is no conformational changes.
Journal ArticleDOI

SASBDB: Towards an automatically curated and validated repository for biological scattering data

TL;DR: The overall organization and procedures of SASBDB are described, paying most attention to user‐relevant information during submission, which is a comprehensive, free and searchable repository of SAS experimental data and models deposited together with the relevant experimental conditions, sample details and instrument characteristics.
Journal ArticleDOI

Allosteric Modulator Discovery: From Serendipity to Structure-Based Design.

TL;DR: This Perspective aimed to increase the awareness of the feasibility of the structure-based discovery of allosteric modulators using an integrated computational and experimental paradigm and highlighted successful examples with their combined applications.
References
More filters
Journal ArticleDOI

Comparative Protein Modelling by Satisfaction of Spatial Restraints

TL;DR: A comparative protein modelling method designed to find the most probable structure for a sequence given its alignment with related structures, which is automated and illustrated by the modelling of trypsin from two other serine proteinases.
Journal ArticleDOI

CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields.

TL;DR: An extension of the CHARMM force field to drug‐like molecules is presented, making it possible to perform “all‐CHARMM” simulations on drug‐target interactions thereby extending the utility ofCHARMM force fields to medicinally relevant systems.
Journal ArticleDOI

Dominant forces in protein folding

TL;DR: The present review aims to provide a reassessment of the factors important for folding in light of current knowledge, including contributions to the free energy of folding arising from electrostatics, hydrogen-bonding and van der Waals interactions, intrinsic propensities, and hydrophobic interactions.
Journal ArticleDOI

Evolutionary Rate at the Molecular Level

TL;DR: Calculating the rate of evolution in terms of nucleotide substitutions seems to give a value so high that many of the mutations involved must be neutral ones.
Related Papers (5)